Multicenter Study to Evaluate Safety and Efficacy of WC3011 (Estradiol Vaginal Cream) in Postmenopausal Women

PHASE3CompletedINTERVENTIONAL
Enrollment

576

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

November 19, 2013

Study Completion Date

November 19, 2013

Conditions
Vulvovaginal Atrophy
Interventions
DRUG

Vehicle

Vehicle Cream applied to the vagina daily for 2 weeks followed by dosing 2 times a week for 10 weeks

DRUG

WC3011 Estradiol Vaginal Cream

WC3011 estradiol vaginal cream applied daily for 2 weeks followed by dosing 2 times a week for 10 weeks

Trial Locations (48)

15206

Warner Chilcott Investigational Study Site, Pittsburgh

19046

Warner Chilcott Investigational Study Site, Jenkintown

19114

Warner Chilcott Investigational Study Site, Philadelphia

23233

Warner Chilcott Investigational Study Site, Richmond

23507

Warner Chilcott Investigational Study Site, Norfolk

27103

Warner Chilcott Investigational Study Site, Winston-Salem

27408

Warner Chilcott Investigational Study Site, Greensboro

28562

Warner Chilcott Investigational Study Site, New Bern

29910

Warner Chilcott Investigational Study Site, Bluffton

30075

Warner Chilcott Investigational Study Site, Roswell

30328

Warner Chilcott Investigational Study Site, Atlanta

31406

Warner Chilcott Investigational Study Site, Savannah

32174

Warner Chilcott Investigational Study Site, Ormond Beach

32216

Warner Chilcott Investigational Study Site, Jacksonville

33143

Warner Chilcott Investigational Study Site, Miami

33186

Warner Chilcott Investigational Study Site, Miami

33409

Warner Chilcott Investigational Study Site, West Palm Beach

33410

Warner Chilcott Investigational Study Site, Palm Beach Gardens

33472

Warner Chilcott Investigational Study Site, Boynton Beach

33759

Warner Chilcott Investigational Study Site, Clearwater

33781

Warner Chilcott Investigational Study Site, Pinellas Park

35801

Warner Chilcott Investigational Study Site, Huntsville

36608

Warner Chilcott Investigational Study Site, Mobile

43213

Warner Chilcott Investigational Study Site, Columbus

44122

Warner Chilcott Investigational Study Site, Cleveland

46530

Warner Chilcott Investigational Study Site, Granger

49009

Warner Chilcott Investigational Study Site, Kalamazoo

70072

Warner Chilcott Investigational Study Site, Marrero

70115

Warner Chilcott Investigational Study Site, New Orleans

75230

Warner Chilcott Investigational Study Site, Dallas

75231

Warner Chilcott Investigational Study Site, Dallas

75234

Warner Chilcott Investigational Study Site, Dallas

77030

Warner Chilcott Investigational Study Site, Houston

78229

Warner Chilcott Investigational Study Site, San Antonio

84109

Warner Chilcott Investigational Study Site, Salt Lake City

84121

Warner Chilcott Investigational Study Site, Salt Lake City

85032

Warner Chilcott Investigational Study Site, Phoenix

85251

Warner Chilcott Investigational Study Site, Scottsdale

85712

Warner Chilcott Investigational Study Site, Tucson

89106

Warner Chilcott Investigational Study Site, Las Vegas

89113

Warner Chilcott Investigational Study Site, Las Vegas

92103

Warner Chilcott Investigational Study Site, San Diego

92108

Warner Chilcott Investigational Study Site, San Diego

92123

Warner Chilcott Investigational Study Site, San Diego

98105

Warner Chilcott Investigational Study Site, Seattle

99207

Warner Chilcott Investigational Study Site, Spokane

06320

Warner Chilcott Investigational Study Site, New London

08057

Warner Chilcott Investigational Study Site, Moorestown

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Warner Chilcott

INDUSTRY

NCT01816139 - Multicenter Study to Evaluate Safety and Efficacy of WC3011 (Estradiol Vaginal Cream) in Postmenopausal Women | Biotech Hunter | Biotech Hunter